KUALA LUMPUR: Biotech product manufacturer and direct-selling company INS Holdings Bhd expects its revenue to grow by 30% this year and to double next year.
Said its chief executive officer Datuk Yeat Sew Chuong: “For the last two years, we have spent RM4mil in investments to penetrate the overseas market. We believe the efforts are coming to fruition.”
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
